For: | Li J, Zhang H, Chen XD. Effect and safety of ripretinib in the treatment of advanced gastrointestinal stromal tumor: A systematic review and meta-analysis. World J Clin Oncol 2024; 15(8): 1092-1101 [PMID: 39193156 DOI: 10.5306/wjco.v15.i8.1092] |
---|---|
URL: | https://www.wjgnet.com/2150-5330/full/v15/i8/1092.htm |
Number | Citing Articles |
1 |
Guanmo Liu, Zicheng Zheng, Jie Li, Yixuan He, Chenggang Zhang, Yihua Wang, Weiming Kang, Xin Ye. Case Report: Neoadjuvant therapy with ripretinib for gastrointestinal stromal tumor: a case report. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1573610
|
2 |
Ahmed Ragab, Reham R. Raslan, Moustafa S. Abusaif, Hamdy Khamees Thabet, Yousry A. Ammar, Nirvana A. Gohar. Discovery and optimization of 2-pyridones as dual h-DHFR/EGFRTK inhibitors with immunomodulatory potential; Design, synthesis, anti-proliferative activity, and apoptosis inducer. European Journal of Medicinal Chemistry 2025; : 117751 doi: 10.1016/j.ejmech.2025.117751
|